| 0.976 | 0.001 | 0.976 | Androgen agonist | | |
| 0.973 | 0.001 | 0.973 | Androgen antagonist | | |
| 0.948 | 0.002 | 0.948 | Aldehyde oxidase inhibitor | | |
| 0.931 | 0 | 0.931 | Anabolic | | |
| 0.881 | 0.001 | 0.881 | Progesterone antagonist | | |
| 0.876 | 0.002 | 0.876 | Estrogen agonist | | |
| 0.821 | 0.002 | 0.821 | Aromatase inhibitor | | |
| 0.806 | 0.001 | 0.806 | Progesterone agonist | | |
| 0.774 | 0.002 | 0.774 | Estrogen receptor alpha antagonist | | |
| 0.716 | 0.003 | 0.716 | Estrogen antagonist | | |
| 0.687 | 0.001 | 0.687 | Glucocorticoid antagonist | | |
| 0.709 | 0.029 | 0.709 | Antiinflammatory | | |
| 0.666 | 0.001 | 0.666 | Lipocortins synthesis antagonist | | |
| 0.665 | 0.004 | 0.665 | Anesthetic general | | |
| 0.677 | 0.023 | 0.677 | Transcription factor NF kappa B inhibitor | | |
| 0.654 | 0.005 | 0.654 | Hypoxia-inducible factor 1 alpha inhibitor | | |
| 0.603 | 0.005 | 0.603 | Diuretic | | |
| 0.586 | 0.002 | 0.586 | Mineralocorticoid receptor antagonist | | |
| 0.549 | 0.003 | 0.549 | Estrogen receptor beta antagonist | | |
| 0.522 | 0.002 | 0.522 | Estrogen receptor alpha agonist | | |
| 0.502 | 0.002 | 0.502 | Aldosterone antagonist | | |
| 0.494 | 0.004 | 0.494 | Sodium/bile acid cotransporter inhibitor | | |
| 0.532 | 0.065 | 0.532 | Apoptosis agonist | | |
| 0.466 | 0.003 | 0.466 | Estrogen receptor beta agonist | | |
| 0.482 | 0.038 | 0.482 | Immunosuppressant | | |
| 0.423 | 0.045 | 0.423 | Cholesterol antagonist | | |
| 0.377 | 0.003 | 0.377 | Estradiol 17 beta-dehydrogenase inhibitor | | |
| 0.313 | 0.017 | 0.313 | Lipid peroxidase inhibitor | | |
| 0.328 | 0.035 | 0.328 | Nitric oxide antagonist | | |
| 0.397 | 0.113 | 0.397 | Caspase 9 stimulant | | |
| 0.28 | 0.003 | 0.28 | Arachidonic acid antagonist | | |
| 0.268 | 0.025 | 0.268 | Interferon gamma antagonist | | |
| 0.315 | 0.076 | 0.315 | Apoptosis antagonist | | |
| 0.236 | 0.006 | 0.236 | Antineoplastic alkaloid | | |
| 0.228 | 0.004 | 0.228 | 5-Alpha-reductase inhibitor | | |
| 0.226 | 0.003 | 0.226 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | | |
| 0.24 | 0.027 | 0.24 | Bone formation stimulant | | |
| 0.248 | 0.04 | 0.248 | Neurotrophic factor enhancer | | |
| 0.205 | 0.003 | 0.205 | RNA-directed RNA polymerase stimulant | | |
| 0.208 | 0.008 | 0.208 | Prolactin inhibitor | | |
| 0.227 | 0.032 | 0.227 | NOS3 expression enhancer | | |
| 0.221 | 0.028 | 0.221 | Monophenol monooxygenase inhibitor | | |
| 0.274 | 0.094 | 0.274 | Interleukin 2 agonist | | |
| 0.247 | 0.068 | 0.247 | DNA synthesis inhibitor | | |
| 0.215 | 0.04 | 0.215 | Antipruritic | | |
| 0.172 | 0.003 | 0.172 | Estrone sulfatase inhibitor | | |
| 0.163 | 0.003 | 0.163 | Estradiol 17 beta-dehydrogenase 3 inhibitor | | |
| 0.159 | 0.013 | 0.159 | Keratolytic | | |
| 0.173 | 0.033 | 0.173 | Farnesoid X receptor antagonist | | |
| 0.144 | 0.009 | 0.144 | Glycine receptor antagonist | | |
| 0.161 | 0.032 | 0.161 | Microtubule formation inhibitor | | |
| 0.159 | 0.039 | 0.159 | Pregnane X receptor agonist | | |
| 0.175 | 0.055 | 0.175 | Acetylcholine M1 receptor antagonist | | |
| 0.196 | 0.076 | 0.196 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | | |
| 0.199 | 0.08 | 0.199 | Psychostimulant | | |
| 0.189 | 0.072 | 0.189 | P-glycoprotein inhibitor | | |
| 0.116 | 0.003 | 0.116 | Lipocortins synthesis agonist | | |
| 0.167 | 0.062 | 0.167 | Melanin inhibitor | | |
| 0.112 | 0.008 | 0.112 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | | |
| 0.142 | 0.039 | 0.142 | Interleukin 8 antagonist | | |
| 0.177 | 0.082 | 0.177 | Hepatoprotectant | | |
| 0.143 | 0.048 | 0.143 | Cholesterol synthesis inhibitor | | |
| 0.114 | 0.02 | 0.114 | Na+ K+ transporting ATPase inhibitor | | |
| 0.115 | 0.03 | 0.115 | Ornithine decarboxylase inhibitor | | |
| 0.198 | 0.115 | 0.198 | Antioxidant | | |
| 0.087 | 0.005 | 0.087 | 5-Alpha-reductase 2 inhibitor | | |
| 0.129 | 0.049 | 0.129 | GABA receptor agonist | | |
| 0.11 | 0.03 | 0.11 | Inducible nitric-oxide synthase inhibitor | | |
| 0.191 | 0.113 | 0.191 | RNA-directed DNA polymerase inhibitor | | |
| 0.099 | 0.022 | 0.099 | Glycine receptor agonist | | |
| 0.077 | 0.002 | 0.077 | Progesterone receptor A antagonist | | |
| 0.077 | 0.005 | 0.077 | 5-Alpha-reductase 1 inhibitor | | |
| 0.132 | 0.06 | 0.132 | DNA polymerase I inhibitor | | |
| 0.078 | 0.008 | 0.078 | Pregnane X receptor antagonist | | |
| 0.106 | 0.036 | 0.106 | Acetylcholine nicotinic antagonist | | |
| 0.072 | 0.003 | 0.072 | Glucocorticoid agonist | | |
| 0.132 | 0.063 | 0.132 | Cholinergic antagonist | | |
| 0.19 | 0.124 | 0.19 | DNA damaging | | |
| 0.129 | 0.063 | 0.129 | Acetylcholine antagonist | | |
| 0.165 | 0.1 | 0.165 | Non-steroidal antiinflammatory agent | | |
| 0.127 | 0.062 | 0.127 | Alkylator | | |
| 0.077 | 0.017 | 0.077 | Heme oxygenase stimulant | | |
| 0.103 | 0.045 | 0.103 | Antineoplastic antibiotic | | |
| 0.06 | 0.007 | 0.06 | Glucose-6-phosphate dehydrogenase inhibitor | | |
| 0.074 | 0.024 | 0.074 | GABA receptor antagonist | | |
| 0.1 | 0.05 | 0.1 | Bile acid receptor antagonist | | |
| 0.074 | 0.024 | 0.074 | GABA A receptor antagonist | | |
| 0.05 | 0.003 | 0.05 | Corticosteroid-like | | |
| 0.05 | 0.005 | 0.05 | Estrogen-related receptor beta antagonist | | |
| 0.121 | 0.079 | 0.121 | Tubulin antagonist | | |
| 0.063 | 0.025 | 0.063 | Acetylcholine M2 receptor agonist | | |
| 0.071 | 0.034 | 0.071 | Beta tubulin antagonist | | |
| 0.036 | 0.004 | 0.036 | Progesterone receptor B antagonist | | |
| 0.068 | 0.037 | 0.068 | Adrenaline uptake inhibitor | | |
| 0.139 | 0.108 | 0.139 | Interleukin 6 antagonist | | |
| 0.068 | 0.04 | 0.068 | 5 Hydroxytryptamine uptake inhibitor | | |
| 0.084 | 0.056 | 0.084 | Estrogen-related receptor beta agonist | | |
| 0.058 | 0.032 | 0.058 | Alpha tubulin antagonist | | |
| 0.031 | 0.011 | 0.031 | Estradiol 17 beta-dehydrogenase 1 inhibitor | | |
| 0.042 | 0.024 | 0.042 | GABA uptake inhibitor | | |
| 0.019 | 0.001 | 0.019 | Transcortin receptor antagonist | | |
| 0.122 | 0.105 | 0.122 | CC chemokine 6 receptor antagonist | | |
| 0.103 | 0.087 | 0.103 | Acetylcholine muscarinic antagonist | | |
| 0.018 | 0.003 | 0.018 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | | |
| 0.02 | 0.007 | 0.02 | Thyroid hormone alpha antagonist | | |
| 0.093 | 0.082 | 0.093 | Toll-Like receptor 4 antagonist | | |
| 0.044 | 0.035 | 0.044 | Parathyroid hormone antagonist | | |
| 0.017 | 0.01 | 0.017 | Vitamin D receptor agonist | | |